4/A

PRIMARY DOCUMENT

Company: IOVANCE BIOTHERAPEUTICS, INC.
Filed: August 26, 2016
Period of Report: August 24, 2016
Accession Number: 0001250853-16-000172

View Document ↗ View on SEC.gov ↗